131 related articles for article (PubMed ID: 14675410)
1. Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors.
Lang P; Bader P; Schumm M; Feuchtinger T; Einsele H; Führer M; Weinstock C; Handgretinger R; Kuci S; Martin D; Niethammer D; Greil J
Br J Haematol; 2004 Jan; 124(1):72-9. PubMed ID: 14675410
[TBL] [Abstract][Full Text] [Related]
2. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
Lang P; Schumm M; Greil J; Bader P; Klingebiel T; Müller I; Feuchtinger T; Pfeiffer M; Schlegel PG; Niethammer D; Handgretinger R
Klin Padiatr; 2005; 217(6):334-8. PubMed ID: 16307419
[TBL] [Abstract][Full Text] [Related]
3. Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
Isidori A; Motta MR; Tani M; Terragna C; Zinzani P; Curti A; Rizzi S; Taioli S; Giudice V; D'Addio A; Gugliotta G; Conte R; Baccarani M; Lemoli RM
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1224-32. PubMed ID: 17889360
[TBL] [Abstract][Full Text] [Related]
4. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
5. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Hicks C; Wong R; Manoharan A; Kwan YL
Ann Hematol; 2007 Aug; 86(8):591-8. PubMed ID: 17492259
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
Levine JE; Wiley J; Kletzel M; Yanik G; Hutchinson RJ; Koehler M; Neudorf S
Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia.
Lang P; Handgretinger R; Niethammer D; Schlegel PG; Schumm M; Greil J; Bader P; Engel C; Scheel-Walter H; Eyrich M; Klingebiel T
Blood; 2003 Feb; 101(4):1630-6. PubMed ID: 12393439
[TBL] [Abstract][Full Text] [Related]
8. Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells.
Bitan M; Shapira MY; Resnick IB; Zilberman I; Miron S; Samuel S; Ackerstein A; Elad S; Israel S; Amar A; Fibach E; Or R; Slavin S
Exp Hematol; 2005 Jun; 33(6):713-8. PubMed ID: 15911096
[TBL] [Abstract][Full Text] [Related]
9. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
11. Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago.
Lang P; Klingebiel T; Schumm M; Handgretinger R; Greil J; Beck JF; Niethammer D; Bader P
Bone Marrow Transplant; 2004 Apr; 33(8):879-80. PubMed ID: 14743191
[No Abstract] [Full Text] [Related]
12. Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia.
Koehl U; Zimmermann S; Esser R; Sörensen J; Grüttner HP; Duchscherer M; Seifried E; Klingebiel T; Schwabe D
Bone Marrow Transplant; 2002 Jun; 29(11):927-30. PubMed ID: 12080359
[TBL] [Abstract][Full Text] [Related]
13. Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients.
Teltschik HM; Heinzelmann F; Gruhn B; Feuchtinger T; Schlegel P; Schumm M; Kremens B; Müller I; Ebinger M; Schwarze CP; Ottinger H; Zips D; Handgretinger R; Lang P
Br J Haematol; 2016 Oct; 175(1):115-22. PubMed ID: 27341180
[TBL] [Abstract][Full Text] [Related]
14. Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia.
Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schauenstein K; Schumm M; Handgretinger R
Bone Marrow Transplant; 2000 Mar; 25(5):513-7. PubMed ID: 10713628
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of megadoses of purified haploidentical stem cells.
Handgretinger R; Schumm M; Lang P; Greil J; Reiter A; Bader P; Niethammer D; Klingebiel T
Ann N Y Acad Sci; 1999 Apr; 872():351-61; discussion 361-2. PubMed ID: 10372137
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT).
Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte JP; Brinch L; Cook G; Deliliers GL; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A
Br J Haematol; 1996 Dec; 95(4):715-23. PubMed ID: 8982051
[TBL] [Abstract][Full Text] [Related]
17. CD133+CD34+ and CD133+CD38+ blood progenitor cells as predictors of platelet engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
Camacho Villa AY; Reyes Maldonado E; Montiel Cervantes LA; Vela Ojeda J
Transfus Apher Sci; 2012 Jun; 46(3):239-44. PubMed ID: 22386660
[TBL] [Abstract][Full Text] [Related]
18. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
[TBL] [Abstract][Full Text] [Related]
19. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
[TBL] [Abstract][Full Text] [Related]
20. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation.
Jaime-Pérez JC; Guillermo-Villanueva VA; Méndez-Ramírez N; Chapa-Rodríguez A; Gutiérrez-Aguirre H; Gómez-Almaguer D
Transfusion; 2009 Nov; 49(11):2390-4. PubMed ID: 19903294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
